| (単位:千ドル) | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 |
|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 29,356 | 46,305 | 38,586 | 37,975 | 31,830 | 29,115 | 24,468 | 16,526 | 19,385 |
| 営業費用 | 36,976 | 56,524 | 49,222 | 48,854 | 43,760 | 38,630 | 32,565 | 23,407 | 27,548 |
| 営業利益 | -36,976 | -56,524 | -49,222 | -48,854 | -43,760 | -38,630 | -32,565 | -23,407 | -27,548 |
| 経常(税引前)利益 | - | - | - | - | - | - | - | -27,029 | -59,096 |
| 純利益 | -36,375 | -55,663 | -46,939 | -46,672 | -5,995 | -43,241 | -41,307 | -27,029 | -62,293 |
| 一株あたり利益 | - | - | - | - | - | -1.03 | -0.89 | -0.56 | -1.02 |
| 希薄化後一株あたり利益 | - | - | - | - | - | -1.03 | -0.89 | -0.56 | -1.02 |
| EBITDA | - |